Enriching patient populations in ICU trials: reducing heterogeneity through machine learning.

Journal: Current opinion in critical care
Published Date:

Abstract

PURPOSE OF REVIEW: Despite the pivotal role of randomized controlled trials (RCTs) in critical care research, many have failed to demonstrate significant benefits, particularly in nutrition interventions. This review highlights how patient heterogeneity affects trial outcomes and explores how artificial intelligence and machine learning can address this issue by identifying subgroups with distinct treatment responses, improving trial design, and enhancing the precision of nutritional interventions.

Authors

  • Wonsuk Oh
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Marinela Veshtaj
    Touro College of Osteopathic Medicine, New York, NY, USA.
  • Ankit Sakhuja
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ankit.sakhuja@mssm.edu.